Use of C1 inhibitor for the prevention of ischemia-reperfusion injury

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9211318
APP PUB NO 20130244941A1
SERIAL NO

13776529

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to the therapeutic and prophylactic use of C1 inhibitor for preventing, reducing and treating ischemia and reperfusion injury. The C1 inhibitor of the present invention is still therapeutically effective when administered after an ischemic period and reperfusion and therefore particularly useful for unforeseen occurrences of ischemic reperfusion such as e.g. a stroke.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
PHARMING INTELLECTUAL PROPERTY B V2300 AL LEIDEN

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
De, Simoni Maria Grazia Milaan, IT 9 281
Mannesse, Maurice Leiden, NL 4 80
Nuijens, Johannes Henricus Heiloo, NL 7 118
Pieper, Frank Heemstede, NL 19 921
Ziere, Gijsbertus Johannes Koudeke, NL 3 77

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jun 15, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00